Related Articles
Norcantharidin reverses cisplatin resistance and inhibits the epithelial mesenchymal transition of human non‑small lung cancer cells by regulating the YAP pathway Retraction in /10.3892/or.2020.7830
Combination treatment with flavonoid morin and telomerase inhibitor MST‑312 reduces cancer stem cell traits by targeting STAT3 and telomerase
USP22 promotes melanoma and BRAF inhibitor resistance via YAP stabilization
Long non‑coding RNA OIP5‑AS1 contributes to cisplatin resistance of oral squamous cell carcinoma through the miR‑27b‑3p/TRIM14 axis
YAP overexpression promotes the epithelial-mesenchymal transition and chemoresistance in pancreatic cancer cells